주식/증권
📉 부정적
PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut
요약
PACB cuts its 2026 revenue outlook after Q2 sales fall 2%, as consumables and EMEA growth fail to offset weaker instruments and Asia-Pacific.